中国实用医药2024,Vol.19Issue(9) :124-127.DOI:10.14163/j.cnki.11-5547/r.2024.09.033

妇科再造丸治疗虚寒性痛经的疗效观察

Observation on the curative effect of Fu-Ke-Zai-Zao Pill on dysmenorrhea of deficiency cold type

吴璇 刘新 宁艳辉
中国实用医药2024,Vol.19Issue(9) :124-127.DOI:10.14163/j.cnki.11-5547/r.2024.09.033

妇科再造丸治疗虚寒性痛经的疗效观察

Observation on the curative effect of Fu-Ke-Zai-Zao Pill on dysmenorrhea of deficiency cold type

吴璇 1刘新 1宁艳辉1
扫码查看

作者信息

  • 1. 510000 中国人民解放军南部战区总医院
  • 折叠

摘要

目的 针对虚寒性痛经患者给予妇科再造丸治疗,对治疗效果及安全性予以观察.方法 240 例虚寒性痛经患者,按照 1~240 发放数字卡片,单号为观察组,双号为对照组,各 120 例,分别采取妇科再造丸联合去氧孕烯炔雌醇片(商品名:妈富隆)治疗与单一妈富隆治疗.比较两组疗效、不良反应发生情况及治疗前及治疗后中医证候积分、疼痛程度、血清学指标[前列腺素E2(PGE2)、前列腺素F2a(PGF2a)].结果 观察组总有效率 96.67%高于对照组的 81.67%,差异明显(P<0.05).治疗后,两组小腹冷痛、肛门坠胀、肢体畏寒、腰骶酸痛积分均低于本组治疗前,且观察组小腹冷痛、肛门坠胀、肢体畏寒、腰骶酸痛积分分别为(0.53±0.13)、(0.64±0.13)、(0.53±0.14)、(0.63±0.21)分,低于对照组的(1.32±0.23)、(1.64±0.51)、(1.12±0.26)、(1.22±0.24)分,差异明显(P<0.05).治疗后,两组视觉模拟评分法(VAS)评分、PGF2a低于本组治疗前,PGE2 高于本组治疗前,且观察组VAS评分(1.12±0.52)分、PGF2a(29.03±3.14)pg/ml低于对照组的(2.83±0.57)分、(34.20±3.57)pg/ml,PGE2(28.57±3.85)pg/ml高于对照组的(25.24±3.64)pg/ml,差异明显(P<0.05).两组不良反应发生率比较差异无统计学意义(P>0.05).结论 妇科再造丸应用于虚寒性痛经治疗中,能够促进患者中医证候及血清学指标改善,缓解疼痛,安全有效.

Abstract

Objective To observe the therapeutic effect and safety of Fu-Ke-Zai-Zao Pill on patients with dysmenorrhea of deficiency cold type.Methods A total of 240 patients with dysmenorrhea of deficiency cold type were distributed with digital cards ranging from 1 to 240,with odd number as the observation group and even number as the control group,each with 120 cases.The observation group was treated with Fu-Ke-Zai-Zao Pill and desogestrel and ethinylestradio tablets(trade name:Marvelon),and the control group was treated with Marvelon alone.The efficacy,occurrence of adverse reactions,traditional Chinese medicine syndrome score,pain intensity,serological indexes[prostaglandin E2(PGE2),prostaglandin F2a(PGF2a)]before and after treatment were compared between the two groups.Results The total effective rate of the observation group was 96.67%,which was higher than 81.67%of the control group,and the difference was significant(P<0.05).After treatment,the scores of lower abdominal pain,anal distension,limb chills,and lumbosacral pain in both groups were lower than those before treatment;in the observation group,the scores of lower abdominal pain,anal distension,limb chills and lumbosacral pain were(0.53±0.13),(0.64±0.13),(0.53±0.14)and(0.63±0.21)points,which were lower than(1.32±0.23),(1.64±0.51),(1.12±0.26)and(1.22±0.24)points in the control group;the difference was significant(P<0.05).After treatment,the visual analogue scale(VAS)score and PGF2a in both groups were lower than those before treatment,and PGE2 was higher than that before treatment;the observation group had VAS score of(1.12±0.52)points and PGF2a of(29.03±3.14)pg/ml,which were lower than(2.83±0.57)points and(34.20±3.57)pg/ml in the control group;the observation group had higher PGE2 of(28.57±3.85)pg/ml than(25.24±3.64)pg/ml in the control group;the difference was significant(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion The application of Fu-Ke-Zai-Zao Pill in the treatment of dysmenorrhea of deficiency cold type can promote the improvement of traditional Chinese medicine syndromes and serological indexes,relieve pain,and it is safe and effective.

关键词

妇科再造丸/虚寒性痛经/中医证候/疼痛/不良反应

Key words

Fu-Ke-Zai-Zao Pill/Dysmenorrhea of deficiency cold type/Traditional Chinese medicine syndrome/Pain/Adverse reactions

引用本文复制引用

出版年

2024
中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
参考文献量12
段落导航相关论文